Show simple item record

dc.contributor.authorHarrold, Leslie R.
dc.date2022-08-11T08:08:12.000
dc.date.accessioned2022-08-23T15:46:14Z
dc.date.available2022-08-23T15:46:14Z
dc.date.issued2011-05-20
dc.date.submitted2011-08-04
dc.identifier.doi10.13028/wfmt-nv05
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27707
dc.description.abstractThe objective of this study was to compare the effectiveness of abatacept to anti-TNFs using the following: Change in disease activity based on the Clinical Disease Activity Index, and (CDAI) Achievement of remission based on the CDAI. Among this small sample of RA patients in a real-world setting, treatment with abatacept was not associated with any differences in response or remission rates from those seen with anti-TNFs based on mean change in CDAI and achievement of CDAI remission. This study suggests similar effectiveness of abatacept and anti-TNFs in biologic naïve RA patients. Further research with a larger sample size is needed to confirm these findings.
dc.formatyoutube
dc.language.isoen_US
dc.rightsCopyright the Author(s)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subjectAnalytical, Diagnostic and Therapeutic Techniques and Equipment
dc.subjectRheumatology
dc.subjectTherapeutics
dc.titleTargeted Therapies in RA: Real World Comparative Effectiveness Research
dc.typePresentation
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1003&context=cts_retreat&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cts_retreat/2011/presentations/3
dc.identifier.contextkey2132937
refterms.dateFOA2022-08-23T15:46:14Z
html.description.abstract<p>The objective of this study was to compare the effectiveness of abatacept to anti-TNFs using the following: Change in disease activity based on the Clinical Disease Activity Index, and (CDAI) Achievement of remission based on the CDAI.</p> <p>Among this small sample of RA patients in a real-world setting, treatment with abatacept was not associated with any differences in response or remission rates from those seen with anti-TNFs based on mean change in CDAI and achievement of CDAI remission. This study suggests similar effectiveness of abatacept and anti-TNFs in biologic naïve RA patients. Further research with a larger sample size is needed to confirm these findings.</p>
dc.identifier.submissionpathcts_retreat/2011/presentations/3


Files in this item

Thumbnail
Name:
Harrold_presentation_Targeted_ ...
Size:
700.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright the Author(s)
Except where otherwise noted, this item's license is described as Copyright the Author(s)